Keytruda® Approved for Small Cell Lung Cancer - DocWire News

Keytruda® Approved for Small Cell Lung Cancer  DocWire News

The Food and Drug Administration (FDA) has granted approval for Keytruda® (pembrolizumab) to treat metastatic small cell lung cancer (SCLC).



Comments

Popular posts from this blog